Hims & Hers Health, Inc. (HIMS)
NYSE: HIMS · Real-Time Price · USD
27.80
-0.10 (-0.36%)
Sep 10, 2026, 12:57 PM EDT - Market open
Hims & Hers Health Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 6,486 | 7,392 | 5,283 | 1,887 | 1,332 | 1,336 | |
Market Cap Growth | -42.19% | 39.92% | 180.00% | 41.69% | -0.30% | 263.65% |
Enterprise Value | 7,191 | 7,880 | 5,040 | 1,679 | 1,139 | 1,083 |
Last Close Price | 27.90 | 32.47 | 24.18 | 8.90 | 6.41 | 6.55 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | 57.58 | 41.92 | - | - | - |
Forward PE | 78.27 | 55.10 | 47.31 | - | - | - |
PS Ratio | 2.52 | 3.15 | 3.58 | 2.16 | 2.53 | 4.91 |
PB Ratio | 20.09 | 13.67 | 11.08 | 5.48 | 4.27 | 3.99 |
P/TBV Ratio | - | 111.18 | 16.48 | 8.79 | 7.44 | 6.95 |
P/FCF Ratio | 78.40 | 99.94 | 25.23 | 33.53 | - | - |
P/OCF Ratio | 24.71 | 24.64 | 21.04 | 25.68 | - | - |
PEG Ratio | - | 7.65 | - | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 2.80 | 3.36 | 3.41 | 1.93 | 2.16 | 3.98 |
EV/EBITDA Ratio | - | 44.86 | 60.75 | - | - | - |
EV/EBIT Ratio | - | 65.04 | 76.50 | - | - | - |
EV/FCF Ratio | 86.90 | 106.54 | 24.07 | 29.84 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 4.77 | 2.07 | 0.02 | 0.03 | 0.02 | 0.02 |
Debt / EBITDA Ratio | 171.37 | 5.92 | 0.13 | - | - | - |
Debt / FCF Ratio | 18.62 | 15.15 | 0.05 | 0.18 | - | - |
Net Debt / Equity Ratio | 2.18 | 1.00 | -0.61 | -0.61 | -0.56 | -0.72 |
Net Debt / EBITDA Ratio | -69.29 | 3.09 | -3.48 | 12.47 | 2.96 | 2.35 |
Net Debt / FCF Ratio | 8.49 | 7.34 | -1.38 | -3.75 | 5.96 | 6.86 |
Asset Turnover | 0.94 | 1.64 | 2.57 | 2.16 | 1.34 | 1.01 |
Inventory Turnover | 6.84 | 8.50 | 6.98 | 7.13 | 6.73 | 7.88 |
Quick Ratio | 0.82 | 1.51 | 1.38 | 2.57 | 3.81 | 3.17 |
Current Ratio | 0.93 | 1.90 | 1.79 | 3.00 | 4.52 | 3.41 |
Return on Equity (ROE) | -32.03% | 25.23% | 30.71% | -7.18% | -20.32% | -49.19% |
Return on Assets (ROA) | -2.21% | 5.29% | 7.17% | -4.09% | -10.54% | -24.79% |
Return on Capital Employed (ROCE) | -4.50% | 6.90% | 13.60% | -7.50% | -20.80% | -31.30% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -2.18% | 1.74% | 2.39% | -1.25% | -4.93% | -8.06% |
FCF Yield | 1.28% | 1.00% | 3.96% | 2.98% | -2.20% | -2.64% |
Buyback Yield / Dilution | 7.33% | -9.05% | -13.12% | -2.36% | -9.50% | -428.32% |